These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 28832288)

  • 21. Impact of hepatitis B virus infection on HIV response to antiretroviral therapy in a Chinese antiretroviral therapy center.
    Yang R; Gui X; Xiong Y; Gao SC; Yan Y
    Int J Infect Dis; 2014 Nov; 28():29-34. PubMed ID: 25236390
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CD4 cell count variability with repeat testing in South Africa: Should reporting include both absolute counts and ranges of plausible values?
    Daniel Francois Venter W; Chersich MF; Majam M; Akpomiemie G; Arulappan N; Moorhouse M; Mashabane N; Glencross DK
    Int J STD AIDS; 2018 Nov; 29(11):1048-1056. PubMed ID: 29749876
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Incidence and predictors of recovery from anaemia within an HIV-infected South African Cohort, 2004-2010.
    Ndlovu Z; Chirwa T; Takuva S
    Pan Afr Med J; 2014; 19():114. PubMed ID: 25722787
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Initiating antiretroviral therapy for HIV at a patient's first clinic visit: a cost-effectiveness analysis of the rapid initiation of treatment randomized controlled trial.
    Long LC; Maskew M; Brennan AT; Mongwenyana C; Nyoni C; Malete G; Sanne I; Fox MP; Rosen S
    AIDS; 2017 Jul; 31(11):1611-1619. PubMed ID: 28463879
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cytopenias among ART-naive patients with advanced HIV disease on enrolment to care and treatment services at a tertiary hospital in Tanzania: A cross-sectional study.
    Gunda DW; Godfrey KG; Kilonzo SB; Mpondo BC
    Malawi Med J; 2017 Mar; 29(1):43-52. PubMed ID: 28567196
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparisons of anemia, thrombocytopenia, and neutropenia at initiation of HIV antiretroviral therapy in Africa, Asia, and the Americas.
    Firnhaber C; Smeaton L; Saukila N; Flanigan T; Gangakhedkar R; Kumwenda J; La Rosa A; Kumarasamy N; De Gruttola V; Hakim JG; Campbell TB
    Int J Infect Dis; 2010 Dec; 14(12):e1088-92. PubMed ID: 20961784
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of point-of-care CD4 cell count results on linkage to care and antiretroviral initiation during a home-based HIV testing campaign: a non-blinded, cluster-randomised trial.
    Desai MA; Okal DO; Rose CE; Ndivo R; Oyaro B; Otieno FO; Williams T; Chen RT; Zeh C; Samandari T
    Lancet HIV; 2017 Sep; 4(9):e393-e401. PubMed ID: 28579225
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prevalence of hepatitis B virus (HBV) co-infection in HBV serologically-negative South African HIV patients and retrospective evaluation of the clinical course of mono- and co-infection.
    Firnhaber C; Chen CY; Evans D; Maskew M; Schulz D; Reyneke A; Kramvis A
    Int J Infect Dis; 2012 Apr; 16(4):e268-72. PubMed ID: 22305987
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Low prevalence of depressive symptoms among stable patients on antiretroviral therapy in Johannesburg, South Africa.
    Shearer K; Evans D; Xhosa B; Hirasen K; Bracken C; Mahomed K; Long L; Fox MP
    PLoS One; 2018; 13(9):e0203797. PubMed ID: 30252844
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The cost-effectiveness of herpes simplex virus-2 suppressive therapy with daily aciclovir for delaying HIV disease progression among HIV-1-infected women in South Africa.
    Vickerman P; Devine A; Foss AM; Delany-Moretlwe S; Mayaud P; Meyer-Rath G
    Sex Transm Dis; 2011 May; 38(5):401-9. PubMed ID: 21317689
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment guidelines and early loss from care for people living with HIV in Cape Town, South Africa: A retrospective cohort study.
    Katz IT; Kaplan R; Fitzmaurice G; Leone D; Bangsberg DR; Bekker LG; Orrell C
    PLoS Med; 2017 Nov; 14(11):e1002434. PubMed ID: 29136014
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Severe adverse events during second-line tuberculosis treatment in the context of high HIV Co-infection in South Africa: a retrospective cohort study.
    Schnippel K; Berhanu RH; Black A; Firnhaber C; Maitisa N; Evans D; Sinanovic E
    BMC Infect Dis; 2016 Oct; 16(1):593. PubMed ID: 27769174
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Outcomes of starting first-line antiretroviral therapy in hepatitis B virus/HIV-coinfected patients in Ghana.
    Chadwick D; Ankcorn M; Sarfo F; Phillips R; Fox Z; Garcia A; Appiah L; Bedu-Addo G; Geretti AM
    J Antimicrob Chemother; 2012 Dec; 67(12):2939-42. PubMed ID: 22915461
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lamivudine-resistant HBV infection in HIV-positive patients receiving antiretroviral therapy in a public routine clinic in Cameroon.
    Kouanfack C; Aghokeng AF; Mondain AM; Bourgeois A; Kenfack A; Mpoudi-Ngolé E; Ducos J; Delaporte E; Laurent C
    Antivir Ther; 2012; 17(2):321-6. PubMed ID: 22290198
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Liver function test abnormalities in Nigerian patients with human immunodeficiency virus and hepatitis B virus co-infection.
    Iroezindu MO; Agbaji OO; Daniyam CA; Isiguzo GC; Isichei C; Akanbi MO
    Int J STD AIDS; 2013 Jun; 24(6):461-7. PubMed ID: 23970749
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CD4+ T-cell Count may not be a Useful Strategy to Monitor Antiretroviral Therapy Response in HTLV-1/HIV Co-infected Patients.
    Vandormael A; Rego F; Danaviah S; Carlos Junior Alcantara L; Boulware DR; de Oliveira T
    Curr HIV Res; 2017; 15(3):225-231. PubMed ID: 28215175
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cohort profile: the Right to Care Clinical HIV Cohort, South Africa.
    Fox MP; Maskew M; Brennan AT; Evans D; Onoya D; Malete G; MacPhail P; Bassett J; Ebrahim O; Mabotja D; Mashamaite S; Long L; Sanne I
    BMJ Open; 2017 Jun; 7(6):e015620. PubMed ID: 28601835
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Trends in and correlates of CD4+ cell count at antiretroviral therapy initiation after changes in national ART guidelines in Rwanda.
    Mutimura E; Addison D; Anastos K; Hoover D; Dusingize JC; Karenzie B; Izimukwiye I; Mutesa L; Nsanzimana S; Nash D;
    AIDS; 2015 Jan; 29(1):67-76. PubMed ID: 25562492
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Short-term risk of anaemia following initiation of combination antiretroviral treatment in HIV-infected patients in countries in sub-Saharan Africa, Asia-Pacific, and central and South America.
    Zhou J; Jaquet A; Bissagnene E; Musick B; Wools-Kaloustian K; Maxwell N; Boulle A; Wehbe F; Masys D; Iriondo-Perez J; Hemingway-Foday J; Law M;
    J Int AIDS Soc; 2012 Jan; 15(1):5. PubMed ID: 22289654
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prevalence of risk factors for chronic kidney disease in South African youth with perinatally acquired HIV.
    Frigati L; Mahtab S; Nourse P; Ray P; Perrazzo S; Machemedze T; Agyei NA; Cotton M; Myer L; Zar H
    Pediatr Nephrol; 2019 Feb; 34(2):313-318. PubMed ID: 30219929
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.